Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy

被引:9
作者
Liu, Zihan [1 ]
Liu, Xinping [1 ]
Zhang, Wei [1 ]
Gao, Ruijie [1 ]
Wei, Hua [1 ]
Yu, Cui-Yun [1 ]
机构
[1] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dru, Sch Pharmaceut Sci, Hengyang Med Sch, Hengyang 421001, Peoples R China
基金
中国国家自然科学基金;
关键词
Hypoxia; Nanotechnology; Tumor microenvironment; Therapeutic resistance; PHOTODYNAMIC THERAPY; CALCIUM PEROXIDE; CLINICAL-TRIAL; BREAST-CANCER; OXYGEN; MICROENVIRONMENT; NANOPARTICLES; NANOZYMES; DELIVERY; CELLS;
D O I
10.1016/j.actbio.2024.01.010
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Hypoxia is a common feature of most solid tumors, which promotes the proliferation, invasion, metastasis, and therapeutic resistance of tumors. Researchers have been developing advanced strategies and nanoplatforms to modulate tumor hypoxia to enhance therapeutic effects. A timely review of this rapidly developing research topic is therefore highly desirable. For this purpose, this review first introduces the impact of hypoxia on tumor development and therapeutic resistance in detail. Current developments in the construction of various nanoplatforms to enhance tumor treatment in response to hypoxia are also systematically summarized, including hypoxia-overcoming, hypoxia-exploiting, and hypoxia-disregarding strategies. We provide a detailed discussion of the rationale and research progress of these strategies. Through a review of current trends, it is hoped that this comprehensive overview can provide new prospects for clinical application in tumor treatment.
引用
收藏
页码:1 / 27
页数:27
相关论文
共 303 条
  • [1] The adenosine pathway in immuno-oncology
    Allard, Bertrand
    Allard, David
    Buisseret, Laurence
    Stagg, John
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (10) : 611 - 629
  • [2] An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers
    An, Jing
    Tang, Shanliang
    Hong, Gaobo
    Chen, Wenlong
    Chen, Miaomiao
    Song, Jitao
    Li, Zhiliang
    Peng, Xiaojun
    Song, Fengling
    Zheng, Wen-Heng
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
    Ansari, Mohammad Javed
    Bokov, Dmitry
    Markov, Alexander
    Jalil, Abduladheem Turki
    Shalaby, Mohammed Nader
    Suksatan, Wanich
    Chupradit, Supat
    Al-Ghamdi, Hasan S.
    Shomali, Navid
    Zamani, Amir
    Mohammadi, Ali
    Dadashpour, Mehdi
    [J]. CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [4] Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both?
    Augustin, Hellmut G.
    Koh, Gou Young
    [J]. CANCER RESEARCH, 2022, 82 (01) : 15 - 17
  • [5] The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
    Bai, Ruixue
    Li, Yunong
    Jian, Lingyan
    Yang, Yuehui
    Zhao, Lin
    Wei, Minjie
    [J]. MOLECULAR CANCER, 2022, 21 (01)
  • [6] Gain an advantage from both sides: Smart size-shrinkable drug delivery nanosystems for high accumulation and deep penetration
    Bai, Shuang
    Zhang, Yang
    Li, Dengfeng
    Shi, Xiaoxiao
    Lin, Gan
    Liu, Gang
    [J]. NANO TODAY, 2021, 36
  • [7] Hypoxia-Mediated ROS Amplification Triggers Mitochondria-Mediated Apoptotic Cell Death via PD-L1/ROS-Responsive, DualTargeted, Drug-Laden Thioketal Nanoparticles
    Banstola, Asmita
    Poudel, Kishwor
    Pathak, Shiva
    Shrestha, Prakash
    Kim, Jong Oh
    Jeong, Jee-Heon
    Yook, Simmyung
    [J]. ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (19) : 22955 - 22969
  • [8] Active mitochondrial respiration in cancer: a target for the drug
    Bedi, Minakshi
    Ray, Manju
    Ghosh, Alok
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (02) : 345 - 361
  • [9] The Acidic Tumor Microenvironment as a Driver of Cancer
    Boedtkjer, Ebbe
    Pedersen, Stine F.
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, VOL 82, 2020, 82 : 103 - 126
  • [10] Borghetti G, 2016, CIRC RES, V119